News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orexo AB (ORXOF) Announces A New MSEK 200 Credit Facility



12/12/2013 9:14:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News:

Orexo AB, “Orexo” (OTCQX: ORXOY; NASDAQ OMX Stockholm: ORX) announces closing of a MSEK 200 (MUSD 30) revolving credit facility with Danske Bank. MSEK 100 will be available immediately upon closing and the remaining MSEK 100 when specific Zubsolv® revenue milestones are met. The facility has a two year tenure with an extension option and the facility replaces the existing overdraft facility of MSEK 50.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Orexo AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES